about
Structural bacterial molecules as potential candidates for an evolution of the classical concept of probioticsIrritable bowel syndrome: a concise review of current treatment conceptsIdentification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells.Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations.Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic ScienceLive Combined Bacillus subtilis and Enterococcus faecium Ameliorate Murine Experimental Colitis by ImmunosuppressionRecommendations for probiotic use in humans-a 2014 updateNo evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.Probiotics to counteract biofilm-associated infections: promising and conflicting dataHow patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndromePerceptions about probiotic yogurt for health and nutrition in the context of HIV/AIDS in Mwanza, TanzaniaLactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agentsProbiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection.Dietary treatment of cows' milk protein allergy in childhood: a commentary by the Committee on Nutrition of the French Society of Paediatrics.Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.Surface protein Esp enhances pro-inflammatory cytokine expression through NF-κB activation during enterococcal infection.Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood.Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.Ability of a high-total antioxidant capacity diet to increase stool weight and bowel antioxidant status in human subjects.An analysis of online messages about probiotics.Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults--a meta-analysis.FISH analysis of Lactobacillus biofilms in the gastrointestinal tract of different hosts
P2860
Q26996471-4BB9BDBB-D047-4DDA-943C-62F77402E23BQ26996547-DBB5DC05-62FD-4D4E-BE78-46FF82184DA5Q33748237-C408DC8A-FA1E-4E68-87A1-1504C5C571CDQ33888804-9AF6E4DD-67A0-4700-AA60-4A707C80B77BQ34089565-16E25755-8EE7-489C-8E5D-6A9FC5B9C8F4Q34162963-23A17461-6930-473D-882C-B6B344878392Q34222447-B342FD43-BCE5-4BDF-A7BE-225CE68237F5Q34411373-F20A57CC-BF26-4E67-81C4-25FB9CCD501BQ34600094-6D040957-08FC-449E-A173-BCCFFB71D2A7Q34623738-713957C2-761E-41B4-BDC8-575EEFDEA686Q35278680-B0B4D385-E1E6-4568-83A9-C34841168813Q35457152-6671812A-7445-4993-8BA4-DD93F1ADB03AQ35852852-C206B06D-A0E0-4F38-B023-9DC5670544F7Q35939274-16681E02-5527-431E-9A22-8AF08D985748Q36018176-CEE7431E-B6E6-4E52-AB5A-522ACC3BC384Q37712802-DCEBE16C-4C6F-4309-A0C9-616D98A5EBE3Q37892873-027E7A7F-2EA4-4EED-BA1D-44DF4E4F4FCCQ37960656-5FCCAD32-1A2C-4738-98DA-C5FF10C1BB8FQ37962875-83737080-89AA-4F27-81BE-E66EAFC9C04EQ37994188-A16C4756-D350-4220-8688-641F65E9C9BAQ38824730-4AC37107-FEBB-4D0D-A2AD-F8D23F3FA05DQ40139300-F6429256-F2B9-43EB-A6D6-5BD908FEFA67Q42844195-2FE6A450-3F76-481D-9966-226AA9327415Q43005153-E6095506-A67F-4A69-A9E0-A68342D8A926Q43008544-9FAC8B67-DE37-4334-AEE5-C07A883970E8Q51028708-D9F26167-C9C7-4C97-B769-3F6D613AA9FFQ57265356-46E3B2D0-44E4-4ECE-8DA4-4D1D37F76A39
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Recommendations for probiotic use--2008.
@ast
Recommendations for probiotic use--2008.
@en
Recommendations for probiotic use--2008.
@nl
type
label
Recommendations for probiotic use--2008.
@ast
Recommendations for probiotic use--2008.
@en
Recommendations for probiotic use--2008.
@nl
prefLabel
Recommendations for probiotic use--2008.
@ast
Recommendations for probiotic use--2008.
@en
Recommendations for probiotic use--2008.
@nl
P2093
P1476
Recommendations for probiotic use--2008.
@en
P2093
Christina Surawicz
Eamonn M M Quigley
Erika Isolauri
Guadalupe Garcia-Tsao
Levinus A Dieleman
Martin H Floch
Mary Ellen Sanders
Patricia Hibberd
Richard N Fedorak
Sherwood Gorbach
P304
P356
10.1097/MCG.0B013E31816B903F
P478
42 Suppl 2
P577
2008-07-01T00:00:00Z